Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine. A and C meningococcal polysaccharide vaccines. The duration of the antibody response to meningococcal vaccination in an African village. Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and children. Ruben FL, Hankins WA, Zeigler Z, et al.
Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen.
McCormick JB, Gusmao HH, Nakamura S, et al. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy. Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables.